WallStreetZenWallStreetZen

NASDAQ: RVNC
Revance Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for RVNC

Based on 5 analysts offering 12 month price targets for Revance Therapeutics Inc.
Min Forecast
$26.00-16.29%
Avg Forecast
$39.60+27.5%
Max Forecast
$48.00+54.54%

Should I buy or sell RVNC stock?

Based on 5 analysts offering ratings for Revance Therapeutics Inc.
Buy
Strong Buy
2 analysts 40%
Buy
2 analysts 40%
Hold
1 analysts 20%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their RVNC stock forecasts and price targets.

RVNC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Needham
Bottom 8%
8
BuyMaintains$44.00+41.66%2023-05-10
HC Wainwright & Co.
Top 8%
93
BuyMaintains$48.00+54.54%2023-05-10
Barclays
Bottom 14%
14
Strong BuyMaintains$40.00+28.78%2023-03-01
Piper Sandler
Top 16%
85
Strong BuyMaintains$40.00+28.78%2023-01-31Find out why
Morgan Stanley
Top 17%
84
HoldMaintains$26.00-16.29%2023-01-24

1 of 1

Forecast return on equity

Is RVNC forecast to generate an efficient return?
Company
N/A
Industry
0.1%
Market
71.95%

Forecast return on assets

Is RVNC forecast to generate an efficient return on assets?
Company
N/A
Industry
0.12%

RVNC revenue growth forecast

How is RVNC forecast to perform vs Biotechnology companies and vs the US market?
Company
59.17%
Industry
39.96%
Market
8.44%
RVNC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
RVNC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

RVNC vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
RVNC$31.06$39.60+27.50%Buy
BEAM$34.03$61.25+79.99%Buy
INSM$19.54$41.00+109.83%Strong Buy
NUVL$44.59$39.00-12.54%Buy
IMVT$20.66$25.91+25.41%Strong Buy
View Top Biotech Stocks

Revance Therapeutics Stock Forecast FAQ

Is Revance Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: RVNC) stock is to Buy RVNC stock.

Out of 5 analysts, 2 (40%) are recommending RVNC as a Strong Buy, 2 (40%) are recommending RVNC as a Buy, 1 (20%) are recommending RVNC as a Hold, 0 (0%) are recommending RVNC as a Sell, and 0 (0%) are recommending RVNC as a Strong Sell.

If you're new to stock investing, here's how to buy Revance Therapeutics stock.

What is RVNC's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: RVNC) forecast ROE is N/A, which is considered weak.

What is RVNC's Price Target?

According to 5 Wall Street analysts that have issued a 1 year RVNC price target, the average RVNC price target is $39.60, with the highest RVNC stock price forecast at $48.00 and the lowest RVNC stock price forecast at $26.00.

On average, Wall Street analysts predict that Revance Therapeutics's share price could reach $39.60 by May 10, 2024. The average Revance Therapeutics stock price prediction forecasts a potential upside of 27.5% from the current RVNC share price of $31.06.

What is RVNC's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: RVNC) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.12%.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.